The GDF5 gene helps guide the growth of bones and joints, especially in the hands, feet, hips, and knees. When it does not work as expected, a person may be born with changes in bone shape, shorter fingers or toes, short stature, or joint problems, and some common variants are linked to a higher chance of osteoarthritis later in life. This gene plays an important role in how cartilage and the ends of bones form during early development.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells can use to make molecules or control processes in the body. Some genes carry the directions for making proteins, the parts of cells that do the work. Others mostly help determine when certain processes happen, where they happen, and how strongly they operate. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
GDF5Gene function
What if the gene works
The GDF5 gene helps guide the growth of bones, joints, and cartilage, especially before birth. It supports normal shaping of the hands, feet, and long bones and helps keep joint tissues working well.
Risk
What if the gene does not work
Variants in the GDF5 gene can affect bone and joint development, ranging from short fingers or toes to more marked limb shortening or joint fusion. Milder and more severe variants can influence which features appear and how noticeable they are.
Treatment
What does that mean for your treatment
No treatment or drug choice tailored to a pathogenic variant in the GDF5 gene is currently established. Research is exploring GDF5 pathways in cartilage repair, osteoarthritis, and bone growth, but this has not yet led to guideline-based care for GDF5 variants.
Conditions associated with GDF5
Gene function
What if the gene works
From early development onward, your body uses the GDF5 gene to guide bone and joint development. Its signals help shape the growing skeleton, especially where bones need to form separate, smooth-moving joints. This background helps explain how your joints and nearby cartilage are built in an organized way over time.
GDF5 helps guide where parts of the developing skeleton form and how they take shape. This signaling is especially important in the hands, feet, and long bones.
GDF5 helps create clear boundaries between developing bones. This allows separate bones to form smooth, movable joints instead of joining into one piece.
GDF5 supports the growth of cartilage, the smooth tissue that covers the ends of bones in joints. This helps joint surfaces develop in a way that supports everyday movement.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help make up normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GDF5 gene can change how much signaling protein is made, how well it folds and leaves the cell, or how strongly it binds its partner receptors. In plain terms, how GDF5 variants affect bone and joint development often depends on how much signaling is left. Milder variants may partly reduce signaling, while more severe variants can greatly lower or stop it, often linking to earlier or more marked skeletal changes. A smaller group of variants can increase signaling and may contribute to joint fusion.
How variants are linked to conditions
Variants in the GDF5 gene are best known for causing several inherited bone growth conditions, including brachydactyly type C, Du Pan syndrome, Grebe dysplasia, and acromesomelic dysplasia, Hunter-Thompson type. Some GDF5 gene variants also cause multiple synostoses syndrome 2. In the general population, common variants in the GDF5 gene are linked to small shifts in height and a higher chance of osteoarthritis, especially in the hip or knee, but these risk linked changes do not mean arthritis will definitely develop.
A variant is not necessarily a diagnosis
Genetic variants are common in the general population and are a normal part of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For common GDF5 changes linked with osteoarthritis, risk is also shaped by age, past joint injuries, and carrying extra body weight, so the gene is only one part of the picture. For rare GDF5 changes that cause a bone growth condition, the genetic change itself is the main driver, and lifestyle does not meaningfully change whether the condition occurs.
Inheritance of GDF5 variants
For the GDF5 gene, the inheritance pattern can differ depending on the specific condition and variant type. Many GDF5-related hand and foot differences are inherited in an autosomal dominant way, which means a parent carrying the variant has a 50% chance of passing it to each child. Other GDF5-related conditions follow an autosomal recessive pattern, meaning a child inherits one altered copy from each parent. This mixed pattern is the key point in understanding how GDF5 variants are inherited.
What does my GDF5 result mean for my family?
GDF5 results can have different family implications because this gene is linked to more than one inherited bone growth condition. In families with a dominant GDF5 change, a parent, child, brother, or sister may also carry the same change and may have similar hand, foot, or joint findings, sometimes milder. In families with a recessive GDF5 condition, parents are often healthy carriers, and brothers or sisters may be affected or be carriers too.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the GDF5 gene usually uses a blood or saliva sample to read your DNA. GDF5 genetic testing looks for spelling changes, small missing or extra pieces, or other variants, and the lab compares them with known findings to show whether a variant was found.
When should I consider getting a genetic test?
Genetic testing for the GDF5 gene may be worth considering if you or your child has unusually short fingers or toes, joint stiffness or fused joints, or a bone growth condition that affects height or limb shape. It can also help when these features run in the family or when doctors are trying to confirm the cause of a skeletal condition.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and on the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly or more quickly than another, which can change how well the treatment works or how likely side effects are. These differences are common and are one reason the same medication can feel very different from one person to the next.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can affect a person’s response to medications. It examines connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. To explore this subject further, you can read more in the LearnHub.
Drugs influenced by the GDF5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so questions about treatment, side effects, or new symptoms are best discussed with your doctor.
History
Throughout history, people have described families with unusually short fingers, short stature, or hip and joint changes that were later linked to the GDF5 gene. In the 1990s, researchers connected this gene to inherited differences in bone and joint development after studying both human families and animal models with similar limb features. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped clarify why some skeletal conditions can run in families. The GDF5 gene was also identified under the name CDMP1 in early studies, reflecting its role in cartilage development. Over time, descriptions became more precise. These discoveries made the GDF5 gene an important part of the history of skeletal genetics.